KNAUER is a Berlin-based manufacturer of high-tech scientific instruments with a strong focus on fluid technologies and automation. Solutions include lipid nanoparticle formulation, oligocucleotide synthesis, protein purification, HPLC, dosing and flow chemistry.

KNAUER's LNP production systems are applied, e.g. for mRNA vaccines, therapies with short interfering RNAs, and new liposomal cancer therapies. These devices, which utilize KNAUER Impingement Jets Mixing (IJM) technology, have been used worldwide in the mass production of mRNA COVID-19 vaccines.

Their NanoScaler LNP systems are designed specifically for the pre-scale up R&D of lipid nanoparticle based therapies.

The OligoScaler, KNAUER's fully automated solid-phase oligonucleotide synthesis platform for research and GMP production is built for high purity and high yield oligos. It covers synthesis scales from 100 µmol to 30 mmol and supports all standard modifications (OMe, MOE, thiolation, spacer, GalNAc and more).

Science with Passion